Lion Point Capital, LP BBIO Holdings History
Lion Point Capital, LP's BridgeBio Pharma Inc Holding Summary
As of 2025-03-31, Lion Point Capital, LP held 26,000.00 shares of BridgeBio Pharma Inc(BBIO), totaling $898,820.00. This investment constitutes 5.73% of their stock portfolio, and Lion Point Capital, LP now holds 0.01% of the outstanding BridgeBio Pharma Inc(BBIO) stock.
The initial trade took place in 2024Q2. And since then Lion Point Capital, LP has made 1 purchases of BBIO, at an average price of $27.34, for a total of 49,000.00 shares. In addition, there have been 2 sales at an average price of $30.75 for 23,000.00 shares. Based on historical transaction data and BBIO's current price of $42.78, Lion Point Capital, LP's estimated gain on his BBIO holdings is $479,798.00, reflecting a 35.81% gain to date.
Lion Point Capital, LP BBIO ($42.78) Holding Chart
Lion Point Capital, LP BBIO ($42.78) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
